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Abstract
Motivation: Permutation-based gene set tests are standard approaches
for testing relationships between collections of related genes and an out-
come of interest in high throughput expression analyses. Using M random
permutations, one can attain p-values as small as 1/(M +1). When many
gene sets are tested, we need smaller p-values, hence larger M , to achieve
significance while accounting for the number of simultaneous tests being
made. As a result, the number of permutations to be done rises along
with the cost per permutation. To reduce this cost, we seek parametric
approximations to the permutation distributions for gene set tests.
Results: We focus on two gene set methods related to sums and sums
of squared t statistics. Our approach calculates exact relevant moments
of a weighted sum of (squared) test statistics under permutation. We find
moment-based gene set enrichment p-values that closely approximate the
permutation method p-values. The computational cost of our algorithm
for linear statistics is on the order of doing |G| permutations, where |G| is
the number of genes in set G. For the quadratic statistics, the cost is on
the order of |G|2 permutations which is orders of magnitude faster than
naive permutation. We applied the permutation approximation method
to three public Parkinson’s Disease expression datasets and discovered
enriched gene sets not previously discussed. In the analysis of these ex-
periments with our method, we are able to remove the granularity effects
of permutation analyses and have a substantial computational speedup
with little cost to accuracy.
Availability: Methods available as a Bioconductor package, npGSEA
(www.bioconductor.org).
Contact: larson.jessica@gene.com
1 Introduction
In a genome-wide expression study, researchers often compare the level of gene
expression in thousands of genes between two treatments groups (e.g., disease,
drug, genotype, etc.). Many individual genes may trend toward differential
expression, but will often fail to achieve significance. This could happen for a
set of genes in a given pathway or system (a gene set). A number of significant
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and related genes taken together can provide strong evidence of an association
between the corresponding gene set and treatment of interest. Gene set methods
can improve power by looking for small, coordinated expression changes in a
collection of related genes, rather than testing for large shifts in many individual
genes.
Additionally, single gene methods often assume that all genes are indepen-
dent of each other; this is not likely true in real biological systems. With
known gene sets of interest, researchers can use existing biological knowledge
to drive their analysis of genome-wide expression data, thereby increasing the
interpretability of their results.
Mootha et al. (2003) first introduced gene set enrichment analysis (GSEA)
and calculated gene set p-values based on Kolmogorov-Smirnov statistics. Since
then, there have been many methodological proposals for GSEA; no single one
is always the best. For example, some tests are better for a large number of
weakly associated genes, while others have better power for a small number of
strongly associated genes (Newton et al., 2007).
One of the most important differences among gene set methods is the def-
inition of the null hypothesis. Tian et al., 2005 and Goeman and Bu¨hlmann,
2007 (among others) introduce two null hypotheses that differentiate the gen-
eral approaches for gene set methods. The first measures whether a gene set
is more strongly related with the outcome of interest than a comparably sized
gene set. Methods of this type typically rely on randomizing the gene labels
to test what is often called the competitive null hypothesis. This is problem-
atic because genes are inherently correlated (especially those within a set) and
permuting them does not give a rigorous test (Goeman and Bu¨hlmann, 2007).
The second type of approach is used to determine whether the genes within
a set associate more strongly with the outcome of interest than they would by
chance, had they been independent of the outcome. Methods that test this self-
contained null hypothesis usually judge statistical significance by randomizing
the phenotype with respect to expression data and assume that gene sets are
fixed. While we acknowledge that the competitive hypothesis is often of interest,
we focus on methods that test the self-contained hypothesis in this paper.
A popular self-contained GSEA method is the JG-score (Jiang and Gentle-
man, 2007), which determines the the level of enrichment based on averaging
linear model statistics. Recently, Ackermann and Strimmer (2009) compared
261 different gene set tests, and found particularly good performance from a
sum of squared single gene regression coefficients. We extend both the sum and
the sum of squared linear statistics approaches with a new method in this paper.
All current GSEA methods are based on permutation approaches. The ini-
tial GSEA (Mootha et al., 2003) and JG-score (Jiang and Gentleman, 2007)
methods both have closed form null distributions for their enrichment statistics,
Gaussian and Kolmogorov-Smirnov, respectively; however, even the authors of
these methods acknowledge that these distributions do not give the correct p-
values and suggest the use of permutation. Lehmann and Romano (2005) give
a concise explanation of how permutation inference works. It is common to ap-
proximate the permutation distribution by a large Monte Carlo sample (Eden
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and Yates, 1933; David, 2008).
Permutation tests are simple to program and do not make parametric distri-
butional assumptions. They also can be applied to almost any statistic we might
wish to investigate. However, permutation approaches are often computation-
ally expensive, are subject to random inference, and fail to achieve continuous
p-values. Each of these drawbacks is described in more depth below.
We have developed a new gene set enrichment approach that approximates
the permutation distribution of our corresponding test statistics. We find that
our method of moments techniques result in almost exactly the same p-values as
permutation approaches, but in much less computation time. Through our ap-
proach, we are able to obtain refined p-values and achieve stringent significance
thresholds. We applied our approach to three public expression analyses, and
found disease-associated gene sets not previously discovered in these studies.
2 Methods
2.1 The data
For definiteness, we present our notation using the language of gene expression
experiments. Let g, h, r, and s denote individual genes and G be a set of genes.
The cardinality of G is denoted |G|, or sometimes p. That is the same letter
we use for p-value, but the usages are distinct enough that there should be no
confusion. Our experiment has n subjects. The subjects may represent patients,
cell cultures, or tissue samples.
The expression level for gene g in subject i is Xgi, and Yi is the target
variable on subject i. Yi is often a treatment, disease, or other phenotype. We
center the variables so that
n∑
i=1
Yi =
n∑
i=1
Xgi = 0, ∀g. (1)
The Xgi are not necessarily raw expression values, nor are they restricted to
microarray values. In addition to the centering (1) they could have been scaled
to have a given mean square. The scaling factor for Xgi might even depend
on the sample variance for some genes h 6= g if we thought that shrinking the
variance for gene j towards the others would yield a more stable test statistic
(Smyth, 2005). We might equally use a quantile transformation, replacing the
j′th largest of the raw Xgi by Φ−1((j − 1/2)/n) where Φ is the Gaussian cu-
mulative distribution function. Further preprocessing may be advised to handle
outliers in X or Y . We do require that the preprocessing of the X’s does not
depend on the Y ’s and vice versa.
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2.2 Test statistics
Our measure of association for gene g on our treatment of interest is
βˆg =
1
n
n∑
i=1
XgiYi. (2)
If both Xgi and Yi are centered and standardized to have variance 1, then
βˆg = ρˆg, the sample correlation between Y and gene g. The usual t-statistic for
testing a linear relationship between these variables is tg ≡
√
n− 2ρˆg/(1−ρˆ2g)1/2,
which is a monotone transformation of ρˆg.
For reasons of power and interpretability, we apply gene set testing methods
instead of just testing individual genes. Linear and quadratic test statistics have
been found to be the best performers for gene set enrichment analyses; we thus
consider two statistics for our approach:
T̂G,w =
∑
g∈G
wgβˆg and ĈG,w =
∑
g∈G
wgβˆ
2
g .
The statistic T̂G,w can approximate the JG score of Jiang and Gentleman
(2007). The JG score is (1/
√|G|)∑g∈G tg. Taking wg = √n− 2/(sd(Xg)sd(Y )),
where sd denotes a standard deviation, weights genes similarly to the JG score.
Although T̂G,w with these weights sums statistics equivalent to t statistics, it
is not exactly equivalent to the sum of those statistics because of the way ρˆg
appears in the denominator of each tg.
The statistic ĈG,w is a weighted sum of squared sample covariances. Ack-
ermann and Strimmer (2009) conducted an extensive simulation of gene set
methods and found good results for quadratic combinations of per gene test
statistics.
The letters T and C are mnemonics for the t and χ2 distributions that
resemble the permutation distributions of these quantities. The wg are scalar
weights. For the quadratic statistics we will suppose that wg > 0. We won’t
need that condition to find moments of CG,w, but because we will compare CG,w
to a χ2 distribution, it is reasonable to avoid negative weights. Non-negative
weights are also used to simplify our algorithm.
Although linear and quadratic test statistics are fairly restricted, they do
allow a reasonable amount of customization through the weights wg, and they
are very interpretable compared to more ad hoc statistics.
2.3 Permutation procedure
A permutation of {1, 2, . . . , n} is a reordering of {1, 2, . . . , n}. There are n!
permutations. We call pi a uniform random permutation of {1, 2, . . . , n} if it
equals each distinct permutation with probability 1/n!.
In a permutation analysis, we replace Yi by Y˜i where Y˜i = Ypi(i) for i =
1, . . . , n. Then β˜g = (1/n)
∑n
i=1XgiY˜i, and when Y˜ is substituted for Y , T̂G,w
becomes T˜G,w and ĈG,w becomes C˜G,w.
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The n! different permutations form a reference distribution from which we
can compute p-values. There are often so many possible permutations that we
cannot calculate or use all of them. Instead, we independently sample uniform
random permutations M times, getting statistics C˜m = C˜G,w,m, and similarly
T˜m, for m = 1, . . . ,M . We then compute p-values by comparing our observed
statistics to our permutation distribution:
pQ =
#{C˜m > Ĉ}+ 1
M + 1
pC =
#{|T˜m| > |T̂ |}+ 1
M + 1
pL =
#{T˜m 6 T̂}+ 1
M + 1
, or pR =
#{T˜m > T̂}+ 1
M + 1
,
where pQ and pC are p-values for two-sided inferences on the quadratic and linear
statistic, respectively, and pL (left) and pR (right) are for one-sided inferences
based on the linear statistic. We use the mnemonic C in pC to denote the central
(or two-sided) p-value, which corresponds to a central confidence interval. The
+1 in numerator and denominator of the p-values corresponds to counting the
sample test statistic as one of the permutations. That is, we automatically
include an identity permutation.
2.4 Permutation disadvantages
There are three main disadvantages to permutation-based analyses: cost, ran-
domness, and granularity.
Testing many sets of genes becomes computationally expensive for two rea-
sons. First, there are many test statistics to calculate in each permuted version
of the data. Second, to allow for multiplicity adjustment, we require small nom-
inal p-values to draw inference about our sets, which in turn requires a large
number of permutations. That is, to obtain a small adjusted p-value (e.g., via
FDR, FWER, Bonferroni methods), one first needs a small enough raw p-value.
In order to obtain small raw p-values, the number of permutations (M) must
be large, thereby increasing computational cost.
Because permutations are based on a random shuffling of the data, there is
a chance that we will obtain a different p-value for our set of interest each time
we run our permutation analysis. That is, our inference is subject to a given
random seed.
Permutations also have a granularity problem. If we do M permutations,
then the smallest possible p-value we can attain is 1/(M + 1). At or below
this minimum p-value permutation tests have no power. Knijnenburg et al.
(2009) suggest that for a reliable p-value, there should be at least 10 permuted
values more extreme than the sample. That requires M ≈ 10/p and when it
is necessary, due to test multiplicity, to use small p such as 10−6 or smaller,
the permutation approach becomes computationally expensive. We call this the
sample granularity problem.
There is also a population granularity problem. In an experiment with n
observations, the smallest possible p-value is at least 1/n!. Sometimes the at-
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tainable minimum is much larger. For instance, when the target variable Y is
binary with n/2 positive and n/2 negative values then the smallest possible p-
value is 1/
(
n
n/2
)
. For n = 10 we necessarily have p > 1/252. Rotation sampling
methods such as ROAST are able to get around this population granularity
problem (Wu et al., 2010). Increased Monte Carlo sampling can mitigate the
sample granularity problem but not the population granularity problem.
Another aspect of the granularity problem is that permutations give us no
basis to distinguish between two gene sets that both have the same p-value
1/(M + 1). There may be many such gene sets, and they have meaningfully
different effect sizes. Many current approaches solve this problem by ranking sig-
nificantly enriched gene sets by their corresponding test statistics. This practice
only works if all test statistics have the same null distribution and correlation
structure, which is not the case for many current GSEA methods. Additionally,
the resulting broken ties do not have a p-value interpretation and cannot be di-
rectly used in multiple testing methods. To break ties in this way also requires
the retention of both a p-value and a test statistic for inference, rather than just
one value.
Because of each of these limitations of permutation testing, there is a need
to move beyond permutation-based GSEA methods. The methods we present
below are not as computationally expensive, random, or granular as their per-
mutation counterparts. Our proposal results in a single number on the p-value
scale.
2.5 Moment based reference distributions
To avoid the issues discussed above, we approximate the distribution of the
permuted test statistics T˜G,w by Gaussians or by rescaled beta distributions.
For quadratic statistics C˜G,w we use a distribution of the form σ
2χ2(ν) choosing
σ2 and ν to match the second and fourth moments of C˜G,w under permutation.
For the Gaussian treatment of T˜G,w we find σ
2 = var(T˜G,w) under permuta-
tion using equation (5) of Section 3.3 and then report the p-value
p = Pr(N (0, σ2) 6 T̂G,w),
where T̂G,w is the observed value of the linear statistic. The above is a left tail
p-value. Two-tailed and right-tailed p values are analogous.
When we want something sharper than the normal distribution, we can use
a scaled Beta distribution, of the form A + (B − A)beta(α, β). The beta(α, β)
distribution has a continuous density function on 0 < x < 1 for α, β > 0. We
choose A, B, α and β by matching the upper and lower limits of T˜G,w, as well
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as its mean and variance. Using equation (5) from our theory section we have
A = min
pi
1
n
n∑
i=1
∑
g∈G
wgXgiYpi(i),
B = max
pi
1
n
n∑
i=1
∑
g∈G
wgXgiYpi(i),
α =
A
B −A
( AB
var(T˜G,w)
+ 1
)
, and
β =
−B
B −A
( AB
var(T˜G,w)
+ 1
)
.
(3)
The observed left-tailed p-value is
p = Pr
(
beta(α, β) 6 T̂G,w −A
B −A
)
.
It is easy to find the permutations that maximize and minimize T˜G,w by
sorting the X and Y values appropriately as described in Section 3.3. The
result has A < 0 < B. For the beta distribution to have valid parameters we
must have σ2 < −AB. From the inequality of Bhatia and Davis (2000), we
know that σ2 6 −AB. There are in fact degenerate cases with σ2 = −AB, but
in these cases T˜G,w only takes one or two distinct values under permutation,
and those cases are not of practical interest.
Like us, Zhou et al. (2009) have used a beta distribution to approximate
a permutation. They used the first 4 moments of a Pearson curve for their
approach. Fitting by moments in the Pearson family, it is possible to get a beta
distribution whose support set (A,B) does not even include the observed value.
That is, the observed value is even more extreme than it would have to be to get
p = 0; it is almost like getting p < 0. We chose (A,B) based on the upper and
lower limits of T˜G,w to prevent our observed test statistic from falling outside
the range of possible values of our reference distribution (Section 3.3).
For the quadratic test statistic ĈG,w we use a σ
2χ2(ν) reference distribution
reporting the two-tailed p-value Pr(σ2χ2(ν) > ĈG,w) after matching the first and
second moments of σ2χ2(ν) to E(C˜G,w) and E(C˜
2
G,w) respectively. The parameter
values are
ν = 2
E(C˜G,w)2
var(C˜G,w)
and σ2 =
E(C˜G,w)
ν
=
var(C˜G,w)
2E(C˜G,w)
.
Our formulas for E(C˜G,w) and E(C˜2G,w) under permutation are given in equa-
tion (4) of Section 3.1. Those formulas use E(β˜2g) and cov(β˜2g , β˜2h) which we give
in Corollaries 1 and 2 of Section 3.1.
All of our reference distributions are continuous and unbounded and hence
they avoid the granularity problem of permutation testing. We have prepared
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a publicly available Bioconductor (Gentleman et al., 2004) package, npGSEA,
which implements our algorithm and calculates the corresponding statistics dis-
cussed in this section.
3 Theoretical results
3.1 Permutation moments of test statistics
Under permutation, E(Y˜i) = 0 by symmetry, and so E(β˜g) = 0 too. We easily
find that,
E(T˜G,w) = 0,
var(T˜G,w) =
∑
g∈G
∑
h∈G
wgwhcov(β˜g, β˜h)
E(C˜G,w) =
∑
g∈G
wgE(β˜2g), and
var(C˜G,w) =
∑
g∈G
∑
h∈G
wgwhcov(β˜
2
g , β˜
2
h).
(4)
The means, variances and covariances in (4) are taken with respect to the ran-
dom permutations with the data X and Y held fixed. We adopt the convention
that moments of permuted quantities are taken with respect to the permutation
and are conditional on the X’s and Y ’s. This avoids cumbersome expressions
like E(β˜2g | Xgi, Yi, g ∈ G).
We will need the following even moments of X and Y :
µ2 =
1
n
n∑
i=1
Y 2i , µ4 =
1
n
n∑
i=1
Y 4i ,
X¯gh =
1
n
n∑
i=1
XgiXhi, and
X¯ghrs =
1
n
n∑
i=1
XgiXhiXriXsi
for g, h, r, s ∈ G. Although our derivations involve O(p4) different moments
when the gene set G has p genes, our computations do not require all of those
moments.
Lemma 1. For an experiment with n > 2 including genes g and h,
E(β˜gβ˜h) =
µ2X¯gh
n− 1 .
Proof. See Appendix 1. 
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Corollary 1. For an experiment with n > 2 including genes g and h,
cov(β˜g, β˜h) = µ2X¯gh/(n− 1).
Proof. This follows from Lemma 1 because E(β˜g) = 0.
From Corollary 1, we see that the correlation between permuted test statis-
tics β˜g and β˜h is simply the correlation between expression values for genes g
and h.
Lemma 2. For an experiment with n > 4 including genes g, h, r, s,
E(β˜gβ˜hβ˜rβ˜s) =
(
µ22
µ4
)T
ATB
(
X¯∗ghrs/n
2
X¯ghrs/n
3
)
where X¯∗ghrs = X¯ghX¯rs + X¯gsX¯hr + X¯grX¯hs, with A
T given by0 0
n
n− 1
−n
(n− 1)(n− 2)
3n
(n− 1)(n− 2)(n− 3)
1
−1
n− 1
−1
n− 1
2
(n− 1)(n− 2)
−6
(n− 1)(n− 2)(n− 3)
 ,
and
B =

0 1
0 −4
1 −3
−2 12
1 −6
 .
Proof. See Appendix 2. 
The expression is complicated, but it is simple to compute; we need only
two moments of Y , two cross-moments of X, and the 2 × 2 matrix ATB. The
matrix A depends on the experiment through n. Using Lemma 2 we can obtain
the covariance between β˜2g and β˜
2
h.
Corollary 2. For an experiment with n > 4 and genes g, h,
cov(β˜2g , β˜
2
h) =
(
µ22
µ4
)T
ATB
(
X¯∗gghh/n
2
X¯gghh/n
3
)
− µ
2
2
(n− 1)2 X¯ggX¯hh,
where X¯∗gghh = X¯ggX¯hh + 2X¯
2
gh with A and B as given in Lemma 2.
Proof. The covariance is E(β˜2g β˜2h)−E(β˜2g)E(β˜2h). Applying Lemma 2 to the first
expectation and Lemma 1 to the other two yields the result. 
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3.2 Rotation moments of test statistics
Rotation sampling (Wedderburn, 1975; Langsrud, 2005) provides an alternative
to permutations, and is justified if either X or Y has a Gaussian distribution.
It is simplest to describe when Y ∼ N (µ, σ2In) and even simpler for Y ∼
N (0, σ2In). In the latter case we can replace Y by Y˜ = QY where Q ∈ Rn×n is a
random orthogonal matrix (independent of both X and Y ), and the distribution
of our test statistics is unchanged under the null hypothesis that X and Y are
independent.
Rotation tests work by repeatedly sampling from the uniform distribution
on random orthogonal matrices and recomputing the test statistics using Y˜ in-
stead of Y . They suffer from sample granularity but not population granularity
because Q has a continuous distribution (for n > 2).
To take account of centering we need to use a rotation test appropriate for
Y ∼ N (µ, σ2In). Langsrud (2005) does this by choosing rotation matrices that
leave the population mean fixed. He rotates the data in an n − 1 dimensional
space orthogonal to the vector 1n. To get such a rotation matrix, he first
selects an orthogonal contrast matrix W ∈ Rn×(n−1). This matrix satisfies
WTW = In−1 and WT1n = 0n−1. Then he generates a uniform random rotation
Q∗ ∈ R(n−1)×(n−1) and delivers Y˜ = QY , where Q = 1n1n1Tn +WQ∗WT. More
generally if Y ∼ N (Zγ, σ2In), for a linear model Zγ, Langsrud (2005) shows
how to rotate Y in the residual space of this model, leaving the fits unchanged.
Wu et al. (2010) have implemented rotation sampling for microarray exper-
iments in their method, ROAST. They speed up the sampling by generating a
random vector instead of a random matrix. For some tests, permutations and
rotations have the same moments, and so our approximations are approxima-
tions of rotation tests as much as of permutation tests.
Our rotation method approximation performs very similarly to the permuta-
tion method. We let Y˜ = QY for Q = ( 1n1n1
T
n+WQ
∗WT) where Q∗ is a uniform
random n − 1 × n − 1 rotation matrix and the contrast matrix W ∈ Rn×(n−1)
satisfies WT1n = 0n−1 and WTW = In−1 and then β˜, T˜ and C˜ are defined as
for permutations, substituting Y˜ for Y .
The variance of the quadratic test statistic depends on which contrast matrix
W one chooses, and it cannot always match the permutation variance. This
difference disappears asymptotically as n→∞.
Lemma 3. For an experiment with n > 2 including genes g and h, the moments
E(β˜g) and E(β˜gβ˜h) are identical to their permutation counterparts, regardless
of the choice for W .
Proof. See Appendix 3 and 4. 
Corollary 3. For an experiment with n > 2, E(T˜G,w), var(T˜G,w) and E(C˜G,w)
are the same whether Y˜ is formed by permutation or rotation of Y .
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3.3 Computation and costs
To facilitate computation for the linear statistic, we reduce each gene set to a
single pseudo-gene XGi =
∑
g∈G wgXgi and then let
X¯G =
1
n
n∑
i=1
XGi and X¯GG =
1
n
n∑
i=1
X2Gi.
The weights w have been absorbed into the pseudo-gene to simplify notation.
We define
βˆG =
∑
g∈G
wgβˆg =
1
n
∑
i
XGiYi, and
β˜G =
∑
g∈G
wgβ˜g =
1
n
∑
i
XGiY˜i.
Our permuted linear test statistic is T˜G,w = β˜G, with
var(T˜G,w) = var(β˜G) =
µ2
n− 1X¯GG. (5)
For the beta approximation, we need the range of T˜G,w. Let the sorted
Y values be Y(1) 6 Y(2) 6 . . . 6 Y(n) and the sorted XGi values be XG(1) 6
XG(2) 6 . . . 6 XG(n). Then the range of T˜G,w is [A,B], where
A =
1
n
n∑
i=1
XG(i)Y(n+1−i), and B =
1
n
n∑
i=1
XG(i)Y(i).
For a σt(ν) reference distribution we would also need E(T˜ 4G,w) = E(β˜4G). We
can apply Lemma 2 to the pseudo-gene resulting in
E(β˜4G) =
(
µ22
µ4
)
ATB
(
3X¯2GG/n
2
X¯GGGG/n
3
)
, (6)
where X¯GGGG =
1
n
∑n
i=1X
4
Gi.
We considered using a σt(ν) reference distribution for T˜G,w, taking into ac-
count the fourth moment of T˜G,w (6). We have often (in fact usually) found
that E(T˜ 4G,w) < 3E(T˜ 2G,w)2; that is, lighter tails than the normal. This implies
a negative kurtosis for the permutation distribution, and t distributions have
positive kurtosis. For this reason we use a beta approximation and not a t
approximation.
For the quadratic statistic we have found it useful to replace Xgi by
√
wgXgi
in precomputation. That step is only valid for non-negative wg, but those are
the ones of most interest. Then we use formulas for E(C˜G,w) and var(C˜G,w)
with all wg = wh = 1 (4).
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Now we consider the computational cost. The cost to compute all of the XGi
is dominated by np multiplications. It then takes n more multiplications to get
βˆG and another n to get X¯GGe. It costs n multiplications to get all the µ2, except
that step done once can be used for all gene sets. The cost for the Gaussian
approximation N (0, var(T˜G,w)) is dominated by n(p+ 2) multiplications.
For the beta approximation there is also a cost proportional to n log(n) in
the sorting to compute limits A and B. That adds a cost comparable to a
multiple of log(n) permutations. We judge that the cost of sorting is usually
minor for n and p of interest in bioinformatics.
A permutation analysis requires nM multiplications, after computing XGi,
for a total of n(M + p). It is very common for p to be a few tens and M to be
many thousands or more. Then we can simplify the costs to n(M + p) ≈ nM
and n(2 + p) ≈ np. The moment method costs about as much as doing p
permutations. When the gene set has tens of genes and the permutation method
uses many thousands or even several million permutations, the computational
cost is quite large.
The pseudo-gene technique is more expensive for the quadratic statistics.
The dominant cost in computing ĈG,w is still the np multiplications required to
compute β̂g for g ∈ G. We can also compute E(C˜G,w) in about this amount of
work.
The cost of computing var(C˜G,w) by a straightforward algorithm is at least
np2, because we need X¯gh and X¯gghh for all g, h ∈ G. Some parts of that com-
putation can be sped up to O(np) by rewriting the expression as described in
Appendix 5. One of the terms however does not reduce to O(np). A straightfor-
ward implementation costs O(np2) while an alternative expression costs O(n2p).
The latter is valuable in settings where the gene sets are large compared to the
sample size. In the former case, the moment approximation has cost comparable
to O(p2) permutations. If n < p then the latter case is like np permutations, so
the quadratic cost is comparable to on the order of p ∗min(n, p) permutations.
We have verified our moment formulas by finding that they match values
found by enumerating all n! permutations, for some simulated data sets with
small n. During testing, we also compared permutation and our approximate
p-values on simulated data. We saw a close match but think that an illustration
on real data is more compelling. Section 4 makes comparisons using three
genome wide expression studies in Parkinson’s Disease (PD) patients: Moran
et al. (2006), Scherzer et al. (2007) and Zhang et al. (2005).
4 Parkinson’s Disease
We illustrate our method using publicly available data from three expression
studies in Parkinson’s Disease (PD) patients (Moran et al., 2006, Zhang et al.,
2005, and Scherzer et al., 2007; Table 1). All three experiments contain genome
wide expression values measured via a microarray experiment. PD is a com-
mon neurodegenerative disease; clinical symptoms often include rigidity, resting
tremor and gait instability (Abou-Sleiman et al., 2006). Pathologically, PD
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Reference Tissue # Affected # Controls
Moran Substantia nigra 29 14
Zhang Substantia nigra 18 11
Scherzer Blood 47 21
Table 1: Three data sets used for non-permutation GSEA
is characterized by neuronal-loss in the substantia nigra and the presence of
α-synuclein protein aggregates in neurons (Abou-Sleiman et al., 2006).
Using a selected set from the Broad Institute’s mSigDB v3.1 (Subramanian
et al., 2005) and the presence of PD as a response variable from the Zhang
et al. (2005) dataset, we visualized both permutation distributions and our
approximation of these distributions (Figure 1). As discussed above, we use a
linear test statistic, T̂G,w =
∑
g∈G βˆg, and a quadratic test statistic, ĈG,w =∑
g∈G βˆ
2
g , where βˆg is a sample covariance between gene expression and, in this
case, disease status. Figure 1 shows these two test statistics with a histogram of
99,999 recomputations of those statistics for permutations of treatment status
versus gene expression. In principle, histograms of permuted test statistics can
be very complicated, but in practice, they often resemble familiar parametric
distributions, as in Figure 1.
Using the fitted normal distribution to determine the rarity of the observed
gene set statistic results in a two-tailed p-value of 0.0604 for the linear statistic
while permutations yield p = 0.0595. A fitted σ2χ2(ν) distribution results in
p = 0.0425 for the sum of squares gene set statistic, while permutations yield
p = 0.0458. The p-values are a quite close despite the somewhat higher peak
for the permutation histogram relative to the χ2 density.
We compared our non-permutation p-values to p-values for linear and quadratic
statistics for the 6,303 gene sets from mSigDB’s curated gene sets and Gene On-
tology (GO, Ashburner et al., 2000) gene sets collections (v3.1). One gene set
was removed because it contained only one gene in our experiments. The aver-
age size of these gene sets is 79.40 genes. For our gold standard we ran 999,999
permutations of the linear statistic and 499,999 permutations of the quadratic
statistic. For all of our permutations, we first calculated the observed test statis-
tic for each of the 6,303 gene sets and then permuted the Yi’s M times to obtain
6,303 × M permuted test statistics. We next compared the pre-computed test
statistic vector to our matrix of permuted test statistics.
For each set, we computed left-sided p-values, pL, for the linear statistic and
two-sided p-values, pQ, for the quadratic statistic using these permutations. We
also computed the normal and beta approximations of pL with our method.
(Figure 2, left panel). We converted these one-sided p-values to two-sided p-
values via p = 2 min(pL, 1 − pL). The beta approximation p-values are almost
identical to the permutation p-values.
For our quadratic test statistic, we fit our moment based σ2χ2(ν) approxi-
mation and computed two-sided tailed p-values across all sets (Figure 2, right
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Figure 1: Top panel shows a permutation histogram for a linear test statistic
for the the steroid hormone signaling pathway gene set as described in the text.
The bottom panel shows a quadratic test statistic. Solid red dots indicate the
observed values and curves indicate parametric fits, based on normal and χ2
distributions.
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Figure 2: Permutation p-values (x-axis) versus moment-based p-values (y-axis)
for 6,303 gene sets. The left column represents results for a linear test statistic,
the right column for sum of squares. Data come from three genome-wide ex-
pression studies. We applied the non-linear transformation p1/2 to stretch the
lower range of these distributions for a more informative visual. Red dotted line
represents the line y = x.
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Reference Normal pL Beta pL Normal pC Beta pC Chisq pQ
Moran 0.99991 0.99997 0.99973 0.99991 0.978
Zhang 0.99996 0.99997 0.99983 0.99991 0.990
Scherzer 0.99998 0.99999 0.99991 0.99997 0.994
Table 2: Spearman correlations between gold standard (999,999 and 499,999
permutations for linear and quadratic statistics) and approximation p-values. pL
and pC represent results for one and two-tailed linear test statistics, respectively.
Chisq pQ represents results for the sum of squares analysis.
panel). We see that the smallest χ2 non-permutation p-values are slightly con-
servative. This may reflect the boundedness of the permutation distribution
combined with the unbounded right tail of the χ2 distribution.
In each of the three experiments, there is a tight correlation between the
permutation-based p-values of all sets and both of our moment-based methods
(Table 2). The beta and normal approximations are almost identical. Our beta
approximations are slightly closer to the gold standard than the normal approx-
imations, but not by a practically important amount. The beta approximation
has shorter tails than the Gaussian approximation. It yielded p-values some-
what smaller than permutations did, while the Gaussian approximation yielded
p-values somewhat larger than the permutations did. The χ2 approximations
also reproduce the ranking of the gold standard quite well, though not as well
as the normal and beta approximations to the linear statistic.
For these data sets and 6,303 gene sets, both of the linear statistics, which
have more or less the same rank-ordering of p-values as 999,999 permutations,
could be approximated in about than the amount of time it takes to compute
100 permutations (Table 3, top block). Our gene sets had an average size of
about 80 genes. This lead us to expect that the cost of the linear approximation
would be comparable to doing 80 permutations. We found that the Gaussian
approximation cost about as much as 100 permutations. While this is a close
match, we remark that the time to do M permutations is nearly an affine func-
tion a + bM with positive intercept a. At such small M the overhead costs
dominated the total cost making the per permutation costs hard to resolve.
The beta approximation was slightly slower than the Gaussian one because it
involves the sorting of the data.
The χ2 approximation to the quadratic statistic has a computational cost
about as much as 35,000 to 45,000 permutations, yet has a similar rank-ordering
of p-values 499,999 permutations (Table 3, bottom block). For the quadratic
statistic we expected our algorithm to cost as much as doing a number of per-
mutations equal to a small multiple of the mean square gene set size. It cost
about as much as 35,000 to 45,000 permutations while the mean square set size
was 27,171.
After applying our permutation approximation methods to each dataset in
6,303 mSigDB gene sets, we found many significantly enriched gene sets, even
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Method Moran Zhang Scherzer
M = 100 31.03 29.84 34.71
M = 500 31.95 32.49 35.54
M = 1,000,000 5010.17 4434.77 3933.15
Normal 29.74 27.00 34.66
Beta 30.79 31.88 37.89
M = 30,000 9146.27 7217.59 11808.02
M = 40,000 12256.54 9636.06 16545.60
M = 50,000 16833.08 12564.06 21480.80
M = 500,000 149588.37 129667.73 187067.91
χ2 11020.62 10600.82 12677.15
Table 3: Time in seconds for p-value calculations for 6,303 gene sets in three
genome-wide expression studies. Linear statistic results with M = 100, M =
500, and M = 1,000,000 permutations, and the normal and beta approximations
are in the top block. Timings for the quadratic statistic with M = 30,000, M =
40,000, M = 50,000, and M = 500,000 permutations, and the χ2 approximation
are presented in the bottom block.
after correcting for multiple testing (two-sided adjusted p-value < 0.05). The
most significantly enriched sets are associated with metabolism and mitochon-
drial function, neuronal transmitters and serotonin, epigenetic modifications,
and the transcription factor FOXP3 Supplemental Table 11 Each of these cate-
gories has some previously discovered association with PD, although not through
traditional gene set methods (metabolism and mitochondrial function: Abou-
Sleiman et al. (2006); neuronal transmitters and serotonin: Fox et al. (2009);
epigenetic modifications: Berthier and Pulido (2013); FOXP3: Stone et al.
(2009)). Through our new gene set enrichment method, we discovered a rela-
tionship between the expression of these gene sets and PD.
5 Discussion
Gene set methods are able to pool weak single gene signals over a set of genes to
get a stronger inference. These methods and their corresponding permutation-
based inferences are a staple of high throughput methods in genomics. Because
an experiment for this purpose may have a few to hundreds of microarrays
or RNA-seq samples, permutation can be computationally costly, and yet still
result in granular p-values. In this paper, we introduce an approximation gene
set method, which performs as well as permutation methods, in a fraction of
the computation time and which generates continuous p-values.
Permutation methods have some valuable properties that our approach does
not share. Permutation based inferences give exact p-values. Our approxima-
1 http://statweb.stanford.edu/~owen/reports/SupplementalTable1.xls
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tions are not ordinarily exact because the permutation histogram is not in the
parametric family we use.
The second advantage of permutations is that they apply to arbitrarily com-
plicated statistics. In our view, many of those complicated statistics are much
harder to interpret and are less intuitive than the plain sum and sum of squared
statistics we present. Others have observed that simple linear and squared statis-
tics outperform more complex approaches (Ackermann and Strimmer, 2009).
Our method allows for the weighting of coefficients in our statistics, granting
users access to additional useful and interpretable patterns.
Because of the disadvantages discussed above, there has long been interest
in finding approximations to permutation tests. Eden and Yates (1933) noticed
that the permutation distribution closely matched a parametric distribution
that one would get running an F -test on the same data. It has also been known
since the 1940s that the permutation distribution of the linear test is asymp-
totically normal as n increases (Good, 2004). More recently, Knijnenburg et al.
(2009) approach the granularity issue by taking a random sample of permuta-
tions and fitting a generalized extreme value (GEV) distribution to the tail of
their distribution.
Our work differs from these previous permutation approximation approaches.
We use Gaussian or beta distributions for the linear statistic and a χ2 distri-
bution for the quadratic statistic. These choices never place the observed test
statistic strictly outside the possible range of our reference distribution. In this
way, we also avoid nonsensical p-values.
We have developed a new and intuitive method for gene set enrichment anal-
ysis that is computationally inexpensive, as accurate as permutation methods,
and avoids the sample granularity issue. A Gaussian, beta, or χ2 approximation
gives a principled way to break ties among genes or gene sets whose test statis-
tics are larger than any seen in the M permutations. We applied our moment
based approximations to three human Parkinson’s Disease data sets and dis-
covered the enrichment of several gene sets in this disease, none of which were
mentioned in the original publications.
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Appendix 1: Proof of Lemma 1
This appears in Owen (2005) but we prove it here to keep the paper self-
contained. First
n2E(β˜gβ˜h) =
∑
i
∑
i′
XgiXhi′E(Y˜iY˜i′)
Recall that µ2 =
1
n
∑n
i=1 Y
2
i . Then
E(Y˜iY˜i′) =
µ2, i
′ = i
− 1
n− 1µ2, i
′ 6= i
and so
n2E(β˜gβ˜h) =
∑
i
∑
i′
XgiXhi′E(Y˜iY˜i′)
= µ2
∑
i
∑
i′
XgiXhi′
(
1i=i′ − 1
n− 11i6=i′
)
= µ2
∑
i
∑
i′
XgiXhi′
( n
n− 11i=i′ −
1
n− 1
)
=
n
n− 1µ2
∑
i
XgiXhi
≡ n
2
n− 1µ2X¯gh,
proving Lemma 1. 
Appendix 2: Proof of Lemma 2
The fourth moment contains terms of the form
XgiXhjXrkXs`E(Y˜iY˜j Y˜kY˜`)
and there are different special cases depending on which pairs of indices among
i, j, k and ` are equal. We need the following fourth moments of Y in which all
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indices are distinct:
µ4k = E(Y˜ 4i )
µ3k = E(Y˜ 3i Y˜j)
µ2p = E(Y˜ 2i Y˜ 2j )
µ1p = E(Y˜ 2i Y˜j Y˜k)
µ∅ = E(Y˜iY˜j Y˜kY˜`),
and where the subscripts are mnemonics for terms four of a kind, three of a
kind, two pair, one pair and nothing special.
We can express all of these moments in terms of µ2 and µ4 = (1/n)
∑n
i=1 Y
4
i .
Each moment is a normalized sum over distinct indices. We can write these in
terms of normalized sums over all indices. Many of those terms vanish because∑
i Yi = 0.
Let
∑∗
represent summation over distinct indices, as in
∑∗
ij
fij =
n∑
i=1
n∑
j=1,j 6=i
fij ,
∑∗
ijk
fijk =
n∑
i=1
n∑
j=1,j 6=i
∑
k=1,k 6=i,k 6=j
fijk
and so on. We can write these sums in terms of unrestricted sums:∑∗
ij
fij =
∑
ij
fij −
∑
i
fii∑∗
ijk
fijk =
∑
ijk
fijk −
∑
ij
(fiij + fiji + fijj) + 2
∑
i
fiii, and
∑∗
ijk`
fijk` =
∑
ijk`
fijk` −
∑
ijk
(
fijki + fijkj + fijkk + fijik + fijjk + fiijk
)
+
∑
ij
(
2(fijjj + fijii + fiiji + fiiij) + fijij + fijji + fiijj
)
− 6
∑
i
fiiii.
See Gleich and Owen (2011) for details.
We will use the last expression in a context where fijk` vanishes when
summed over the entire range of any one of its indices. In that case∑∗
ijk`
fijk` =
∑
ij
(
fijij + fijji + fiijj
)
− 6
∑
i
fiiii. (7)
We also use the notation n(k) = n(n− 1)(n− 2) · · · (n− k + 1), often called ‘n
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to k factors’, where k is a positive integer. Now
µ4k =
1
n
n∑
i=1
Y 4i = µ4,
µ3k =
1
n(2)
∑∗
ij
Y 3i Yj =
1
n(2)
(∑
ij
Y 3i Yj −
∑
i
Y 4i
)
= − µ4
n− 1 ,
µ2p =
1
n(2)
∑∗
ij
Y 2i Y
2
j =
1
n(2)
(∑
ij
Y 2i Y
2
j −
∑
i
Y 4i
)
=
1
n− 1
(
nµ22 − µ4
)
, and
µ1p =
1
n(3)
∑∗
ijk
Y 2i YjYk
=
1
n(3)
(∑
ijk
Y 2i YjYk −
∑
ij
(
2Y 3i Yj + Y
2
i Y
2
j
)
+ 2
∑
i
Y 4i
)
=
−nµ22 + 2µ4
(n− 1)(n− 2) .
Finally using (7), n(4)µ∅ equals∑∗
ijk`
YiYjYkY` = 3
∑
ij
Y 2i Y
2
j − 6
∑
i
Y 4i = 3n
2µ22 − 6nµ4
so that
µ∅ =
1
(n− 1)(n− 2)(n− 3)
(
3nµ22 − 6µ4
)
.
We may summarize these results via
µ4k
µ3k
µ2p
µ1p
µ∅
 = A
(
µ22
µ4
)
,
where the matrix A is given in the statement of Lemma 2.
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Now
n4E(β˜gβ˜hβ˜rβ˜s) =
∑
ijk`
XgiXhjXrkXs`E(Y˜iY˜j Y˜kY˜`)
= µ4k
∑
i
XgiXhiXriXsi
+ µ3k
∑∗
ij
(
XgiXhiXriXsj +XgiXhiXrjXsi +XgiXhjXriXsi +XgjXhiXriXsi
)
+ µ2p
∑∗
ij
(
XgiXhiXrjXsj +XgiXhjXriXsj +XgiXhjXrjXsi
)
+ µ1p
∑∗
ijk
(
XgiXhiXrjXsk +XgiXhjXriXsk +XgiXhjXrkXsi
+XgiXhjXrjXsk +XgiXhjXrkXsj +XgiXhjXrkXsk
)
+ µ∅
∑∗
XgiXhjXrkXs`.
Next, we write the terms of n4E(β˜gβ˜hβ˜rβ˜s) using X¯ghrs and similar moments.
The coefficient of µ4k is
∑
iXgiXhiXriXsi = nX¯ghrs. The coefficient of µ3k
contains∑∗
ij
XgiXhiXriXsj =
∑
ij
XgiXhiXriXsj −
∑
i
XgiXhiXriXsi = −nX¯ghrs
and after summing all four such terms, the coefficient is −4nX¯ghrs. The coeffi-
cient of µ2p contains∑∗
ij
XgiXhiXrjXsj =
∑
ij
XgiXhiXrjXsj −
∑
i
XgiXhiXriXsi = −nX¯ghrs
and accounting for all three terms yields −3nX¯ghrs.
The coefficient of µ1p contains∑∗
ijk
XgiXhiXrjXsk =
∑
ijk
XgiXhiXrjXsk −
∑
ij
XgiXhiXriXsj
−
∑
ik
XgiXhiXrjXsi −
∑
jk
XgiXhiXrjXsj + 2
∑
i
XgiXhiXriXsi
= −n2X¯ghX¯rs + 2nX¯ghrs.
Summing all 6 terms, we find that the coefficient is
−2n2(X¯ghX¯rs + X¯grX¯hs + X¯gsX¯hr) + 12nX¯ghrs.
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The coefficient of µ∅ is, using (7),∑∗
ijk`
XgiXhjXrkXs` =
∑
ij
(
XgiXhjXriXsj +XgiXhjXrjXsi +XgiXhiXrjXsj
)
− 6
∑
i
XgiXhiXriXsi
= n2
(
X¯ghX¯rs + X¯grX¯hs + X¯gsX¯hr
)− 6nX¯ghrs.
We may summarize these results via
E(β˜gβ˜hβ˜rβ˜s) =

µ4k
µ3k
µ2p
µ1p
µ∅

T
B
(
X¯∗ghrs/n
2
X¯ghrs/n
3
)
, for B =

0 1
0 −4
1 −3
−2 12
1 −6
 ,
where X¯∗gh,rs = X¯ghX¯rs+ X¯grX¯hs+ X¯gsX¯hr, completing the proof of Lemma 2.
Appendix 3: moments of orthogonal random matrix ele-
ments.
We will need low order moments of orthogonal random matrices to study the
moments of linear and quadratic test statistics under rotation sampling.
For integers n > k > 1, let Vn,k = {Q ∈ Rn×k | QTQ = Ik}, known as the
Stiefel manifold. We will make use of the uniform distributions on Vn,k. There
is a natural identification of Vn,1 with the unit sphere.
Let Q ∈ Rn×n be a uniform random rotation matrix. This implies, among
other things, that each column of Q is a uniform random point on the unit
sphere in n dimensions.
By symmetry, we find that E(Qij) = 0. Similarly E(Q2ij) = E((1/n)
∑n
j=1Q
2
ij) =
1/n and E(QijQrs) = 0 unless i = r and j = s.
Anderson et al. (1987) give
E(Q4ij) =
3
n(n+ 2)
. (8)
We are interested in all fourth moments E(QijQk`QrsQtu) of Q. If any of
j, `, s, u appears exactly once then the fourth moment is 0 by symmetry. To see
this, suppose that index ` appears exactly once. Now define the matrix Q˜ with
elements
Q˜ij =
{
−Qij j = `,
Qij j 6= `.
If Q ∼ U(Vn,n) then Q˜ ∼ U(Vn,n) too by invariance of U(Vn,n) to multiplication
on the right by the orthogonal matrix diag(1, 1, . . . , 1,−1, 1, . . . , 1), with a −1
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in the j′th position. Then
E(QijQk`QrsQtu) =
1
2
E
(
QijQk`QrsQtu + Q˜ijQ˜k`Q˜rsQ˜tu
)
=
1
2
E
(
QijQk`QrsQtu +Qij(−Qk`)QrsQtu
)
= 0.
Similarly, because QT is also uniformly distributed on Vn,n we find that if any
of i, k, r, t appear exactly once the moment is zero. If one index appears exactly
three times, then some other moment must appear exactly once. As a result, the
only nonzero fourth moments are products of squares and pure fourth moments.
Their values are given in the Lemma below.
Lemma 4. Let Q ∼ U(Vn,n). Then
E(Q2ijQ2rs) =

3
n(n+ 2)
, i = r & j = s
1
n(n+ 2)
, 1i=r + 1j=s = 1
n+ 1
n(n− 1)(n+ 2) , i 6= r & j 6= s.
Proof. The first case was given by Anderson et al. (1987).
For the second case, there is no loss of generality in computing E(Q211Q221).
The vector (Q11, Q21, . . . , Qn1) is uniformly distributed on the sphere. Given
Q11, the point (Q21, Q31, . . . , Qn1) is uniformly distributed on the n− 1 dimen-
sional sphere of radius
√
1−Q211. Therefore E(Q221 | Q11) = (1−Q211)/(n− 1)
and so
E(Q211Q221) =
1
n− 1E(Q
2
11 −Q411) =
1
n− 1
(
1
n
− 3
n(n+ 2)
)
=
1
n(n+ 2)
.
For the remaining case we let θ = E(Q2ijQ2rs) for i 6= r and j 6= s. Summing
over n4 combinations of indices we find that
n∑
i=1
n∑
j=1
n∑
r=1
n∑
s=1
Q2ijQ
2
rs =
(∑
ij
Q2ij
)2
= n2
by orthogonality of Q. Therefore
n2 = E
(∑
ij
∑
rs
Q2ijQ
2
rs
)
= n2E(Q411) + 2n2(n− 1)E(Q211Q212) + n2(n− 1)2θ.
Solving for θ we get
θ =
n2 − 3nn+2 − 2n(n−1)n+2
n2(n− 1)2 =
n+ 1
n(n− 1)(n+ 2) .
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Appendix 4: proof of Lemma 3.
Let Xi ∈ Rp where p = |G| and Yi ∈ R for i = 1, . . . , n. Both Xi and Yi are
centered:
∑
iXi = 0 and
∑
i Yi = 0.
The sample coefficients for genes g ∈ G are given by the vector βˆ = L =
(1/n)
∑
iXiYi. The reference distribution is formed by sampling values of β˜ =
(1/n)
∑
iXiY˜i where Y˜ is a rotated version of Y .
The rotation is one that preserves the mean of Y while rotating in the n− 1
dimensional space of contrasts. As in Langsrud (2005), we let W ∈ Rn×(n−1)
be any fixed contrast matrix satisfying WTW = In−1 and WT1n = 0n−1. Then
the rotated version of Y is
Y˜ = WQWTY, where Q ∼ U(Vn−1,n−1)
is a uniform random n− 1 dimensional rotation matrix.
It is convenient to introduce centered quantities Xc = WTX ∈ R(n−1)×p,
Y c = WTY ∈ Rn−1 and Y˜ c = WTY˜ ∈ Rn−1. These sum to zero even when X,
Y and Y˜ do not. Their main difference from those variables is that they have
n− 1 rows, not n.
Now β˜ = (1/n)XTY˜ = (1/n)XTWQWTY = (1/n)XcTQY c, so
E(β˜) = (1/n)XcTE(Q)Y cT = 0.
For the rest of the proof, we need the covariance matrix of β˜. Now
E(β˜β˜T) =
1
n2
XcTE
(
QTY cY cTQ
)
XcT =
1
n2
XcTE
(
QTZQ
)
Xc
where Z = Y cY cT ∈ R(n−1)×(n−1).
The ij element of QTZQ is (QTZQ)ij =
∑n−1
k=1
∑n−1
`=1 Zk`QkiQ`j which has
expected value
n−1∑
k=1
n−1∑
`=1
Zk`1k=`1i=j/(n− 1) = 1i=j
n− 1
n−1∑
k=1
Zkk = 1i=j
n
n− 1µ2
where µ2 = (1/n)
∑n
i=1 Y
2
i = (1/n)
∑n
i=1 Y
c
i
2. That is
E(QTZQ) =
nµ2
n− 1In−1
and so
E(β˜β˜T) =
µ2
n(n− 1)X
cTXc.
In particular E(β˜gβ˜h) = E(β˜β˜T)gh = X¯ghµ2/(n− 1), matching the value under
permutation.
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Appendix 5: cost analysis of var(C˜G,w)
Recall from Corollary 2 that in an experiment with n > 4 and genes g, h,
cov(β˜2g , β˜
2
h) =
(
µ22
µ4
)T
ATB
(
X¯∗gghh/n
2
X¯gghh/n
3
)
− µ
2
2
(n− 1)2 X¯ggX¯hh,
where X¯∗gghh = X¯ggX¯hh + 2X¯
2
gh and A
TB is a given 2× 2 matrix.
To compute
var(C˜G,w) =
∑
g∈G
∑
h∈G
wgwhcov(β˜
2
g , β˜
2
h)
we need µ2, µ4 and A
TB which are very inexpensive. We also need
S1 ≡
∑
g∈G
∑
h∈G
wgwhX¯ggX¯hh =
(∑
g∈G
wgX¯gg
)2
.
By expressing S1 as a square, we find that it can be computed in O(np) work,
not O(np2) which a naive implementation would provide. We can compute all
of the X¯gg’s in np multiplications and this is the largest part of the cost. If gene
g belongs to many gene sets G we only need to compute X¯gg once and so the
cost per additional gene set could be lower.
A similar analysis yields that
S2 ≡
∑
g∈G
∑
h∈G
wgwhX¯gghh =
1
n
n∑
i=1
(∑
g∈G
wgX
2
gi
)2
is also an O(np) computation. Unfortunately S3 ≡
∑
g∈G
∑
h∈G X¯
2
gh does not
reduce to an O(np) computation. As written it costs O(np2). In cases where
p > n, we can however reduce the cost to O(n2p) via
S3 =
∑
g∈G
∑
h∈G
wgwh
(
1
n
n∑
i=1
XgiXhi
)2
=
1
n2
∑
g∈G
∑
h∈G
wgwh
n∑
i=1
XgiXhj
n∑
j=1
XgjXhj
=
1
n2
n∑
i=1
n∑
j=1
(∑
g∈G
wgXgi
)2
.
In terms of these sum quantities,
var(C˜G,w) =
(
µ22
µ4
)T
ATB
(
(S1 + 2S3)/n
3
S2/n
3
)
− µ
2
2
(n− 1)2S1.
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